Standard
Phone
Tablet
Desktop
Large Desktop
Very Large Desktop
---

RealStar® Zika Virus RT-PCR Kit U.S.*

 

The RealStar® Zika Virus RT-PCR Kit U.S.* is a real-time RT-PCR test intended for the in vitro qualitative detection of RNA from the Zika virus in serum, EDTA plasma or urine (collected alongside a patient-matched serum or EDTA plasma specimen):

  • from individuals meeting U.S. Centers for Disease Control and Prevention (CDC) Zika virus clinical criteria (e.g., clinical signs and symptoms associated with Zika virus infection) and/or
  • U.S. CDC Zika virus epidemiological criteria (e.g., history of residence in or travel to a geographic region with active Zika virus transmission at the time of travel).

*only available in USA.   -  For Use Under the Emergency Use Authorization (EUA) Only.

 

The RealStar® Zika Virus RT-PCR Kit U.S.* can also be used with other authorized specimen types and is authorized for a workflow consisting of nucleic acid extraction  using  the  QIAamp®  Viral  RNA  Mini  Kit  (QIAGEN), the MagNA Pure 96 Instrument (Roche) in combination with the MagNA Pure 96 DNA and Viral NA Small Volume Kit (Roche) and the NucliSENS® easyMAG® Instrument (bioMérieux) in combination with the NucliSENS® easyMAG® reagents and disposables (bioMérieux), followed  by  the  amplification  and detection of Zika virus specific RNA using the RealStar® Zika Virus RT-PCR Kit U.S.*.

The test performance for the use with serum and urine samples was validated by the Institute Pasteur de la Guyane, Cayenne, French Guiana.

Please remark:

  • This test has not been FDA-cleared or approved;
  • This test has been authorized by FDA under an EUA for use by CLIA High Complexity Laboratories and similarly qualified non-U.S. laboratories;
  • This test has been authorized only for the detection of RNA from Zika virus and diagnosis of Zika virus infection and not for any other viruses or pathogenes; and
  • This test is only authorized for the duration of the declaration that circumstances exist justifying the authorization of the emergency use of in vitro diagnostics for detection of Zika virus under section 564(b)(1) of the Act, 21 U.S.C. § 360bbb-3(b)(1), unless the authorization is terminated or revoked sooner.

 

Any adverse events should be sent to the following Email adress: support@altona-diagnostics.com

 

RealStar® Zika Virus RT-PCR Kit U.S.*

Order No.591023
Rxns96
Sample typesHuman serum
Human EDTA plasma
Human urine
TransportationDry ice
For use withABI Prism® 7500 SDS and 7500 Fast SDS
LightCycler® 480 Instrument II
Rotor-Gene® 6000
Rotor-Gene® Q 5/6 plex Platfom
CFX96™ Real-Time PCR Detection System and
CFX96™ Deep Well Real-Time PCR Detection System

RealStar® Zika Virus RT-PCR Kit U.S.*

Instructions for use RealStar® Zika Virus RT-PCR Kit U.S.*

pdf
Release Date: 05/2020
Filesize: 1.11 MB

RealStar® Zika Virus RT-PCR Kit U.S.*

Letter of Authorization (Date of EUA issuance 2016-02-12)

pdf
Release Date: 12.02.2016
Filesize: 6.76 MB

Letter Granting EUA Amendment (2017-03-06)

pdf
Release Date: 06.03.2017
Filesize: 130.81 KB

Fact Sheet for Health Care Providers (update 2017-03-06)

pdf
Release Date: 06.03.2017
Filesize: 232.68 KB

Fact Sheet for Patients (update 2017-03-06)

pdf
Release Date: 06.03.2017
Filesize: 218.66 KB